naproxen has been researched along with methotrexate in 63 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (methotrexate) | Trials (methotrexate) | Recent Studies (post-2010) (methotrexate) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 41,593 | 5,666 | 11,969 |
Protein | Taxonomy | naproxen (IC50) | methotrexate (IC50) |
---|---|---|---|
Thymidylate synthase | Escherichia coli | 1.8 | |
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 0.211 | |
Toll-like receptor 4 | Homo sapiens (human) | 1.04 | |
Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.08 | |
Dihydrofolate reductase | Homo sapiens (human) | 0.0522 | |
Dihydrofolate reductase | Mus musculus (house mouse) | 0.0331 | |
Dihydrofolate reductase | Bos taurus (cattle) | 0.0348 | |
Dihydrofolate reductase | Gallus gallus (chicken) | 0.0545 | |
Dihydrofolate reductase | Enterococcus faecium | 0.0014 | |
Dihydrofolate reductase | Lacticaseibacillus casei | 0.0138 | |
Thymidylate synthase | Homo sapiens (human) | 0.343 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0147 | |
Thymidylate synthase | Escherichia coli K-12 | 0.0181 | |
Dihydrofolate reductase | Escherichia coli K-12 | 0.1529 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.084 | |
Folate receptor beta | Homo sapiens (human) | 0.1585 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0011 | |
Cytochrome P450 11B1, mitochondrial | Bos taurus (cattle) | 0.0012 | |
Folate receptor alpha | Homo sapiens (human) | 0.2263 | |
Dihydrofolate reductase | Pneumocystis carinii | 0.0717 | |
Histidine decarboxylase | Rattus norvegicus (Norway rat) | 0.0014 | |
Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.01 | |
Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | 0.01 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
Reduced folate transporter | Homo sapiens (human) | 0.012 | |
Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | 0.0174 | |
Folylpolyglutamate synthase, mitochondrial | Homo sapiens (human) | 3.2 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.0547 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | 0.11 | |
Dihydrofolate reductase | Bacillus anthracis | 0.0136 | |
Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0047 | |
Proton-coupled folate transporter | Homo sapiens (human) | 0.1207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (11.11) | 18.7374 |
1990's | 7 (11.11) | 18.2507 |
2000's | 20 (31.75) | 29.6817 |
2010's | 26 (41.27) | 24.3611 |
2020's | 3 (4.76) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Caron, G; Ermondi, G; Lorenti, M | 1 |
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Alonso-Castro, AJ; Campos-Xolalpa, N; Hernández-Munive, A; Pérez-González, C; Pérez-Gutiérrez, S; Zapata-Morales, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Moen, F | 1 |
Kitchen, EA; Meacock, SC | 1 |
Bradley, JD; Brater, DC; Hall, SD; Jones, DR; Krohn, K; Tracy, TS | 1 |
Calin, A; Elswood, J | 1 |
Arkin, CR; Evans, WE; Fleming, RA; Stewart, CF | 1 |
Guleria, JS; Malaviya, AN; Pandey, JN; Singh, RR | 1 |
Graham, RM; Macfarlane, AW; Ng, HW; Verbov, JL | 1 |
Aarbakke, J; Jaeger, R; Sager, G; Slørdal, L | 1 |
Lee, KT; Lee, WM; Reiner, JM | 1 |
Bracht, A; Ishii-Iwamoto, EL; Nascimento, EA; Yamamoto, NS | 1 |
Balsa, A; Gamallo, C; Gijón-Baños, J; Martín-Mola, E | 1 |
Sherry, DD; Smith, AL; Wallace, CA | 1 |
Andersen, A; Ekstrøm, PO; Giercksky, KE; Slørdal, L | 1 |
Altan, L; Aydiner, S; Bingöl, U; Karakoç, Y; Yurtkuran, M | 1 |
Beri, A; Gupta, A; Khullar, M; Singh, S | 1 |
Chen, J; Liu, C | 1 |
Lovell, DJ; Sullivan, K; Zaoutis, TE | 1 |
Amer, F; Andhivarothai, N; Kukulka, MJ; Vakily, M | 1 |
Kandefer-Szerszeń, M; Majdan, M; Parada-Turska, J; Rzeski, W; Turski, WA | 1 |
Abukawa, D; Ichinohazama, R; Imaizumi, M; Nakano, K; Sato, A; Takeyama, J | 1 |
Chen, J; Lin, J; Liu, C | 1 |
Hashkes, PJ; Laxer, RM | 1 |
Kozic, H; Mendoza, V; Vahid, B; Weibel, S | 1 |
Gupta, R; Kabra, SK; Lodha, R; Verma, S | 1 |
Bazso, A; Consolaro, A; Filocamo, G; Magni-Manzoni, S; Malattia, C; Martini, A; Pistorio, A; Ravelli, A; Ruperto, N; Viola, S | 1 |
Berbegal, J; Femenia, M; Martínez, P; Moreno, D | 1 |
Guo, L; He, D; Jiang, B; Li, Y; Ma, L; Ouyang, L | 1 |
Eliasaf, S; Livneh, A; Naimushin, A | 1 |
Fathalla, BM; Safi, KH | 1 |
Chen, J; Lin, J; Liu, C; Veras, MM | 1 |
Bachmann, F; Blume-Peytavi, U; Garcia Bartels, N; Minden, K; Philipp, S; Stieler, K | 1 |
Disney, B; Perkins, P; Szeto, MC; Wood, G | 1 |
Bouwer, LR; Hutting, KH; Keukens, FM | 1 |
Banerjee, D; Das, A; Gayen, G; Mondal, R | 1 |
Gittler, J; Kahn, P; Meehan, S; Oza, VS; Stringer, T | 1 |
Bordy, R; Demougeot, C; Prati, C; Totoson, P; Verhoeven, F; Wendling, D | 1 |
Dhir, V; Dhooria, A; Jha, S; Kumar, RR; Mittal, S; Rawat, A | 1 |
Ji, H; Sun, Q; Tang, Z | 1 |
Eshaghi, H; Safavi, M; Vasei, M | 1 |
Caron, MMJ; Castermans, TMR; Haartmans, MJJ; van Rhijn, LW; van Rietbergen, B; Welting, TJM; Witlox, AMA | 1 |
Ferraccioli, G; Gremese, E; Zanardi, R | 1 |
7 review(s) available for naproxen and methotrexate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Methotrexate for ankylosing spondylitis.
Topics: Antirheumatic Agents; Humans; Methotrexate; Naproxen; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2004 |
Methotrexate for ankylosing spondylitis.
Topics: Antirheumatic Agents; Humans; Methotrexate; Naproxen; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2006 |
Update on the medical treatment of juvenile idiopathic arthritis.
Topics: Antibodies, Blocking; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Humans; Immunologic Factors; Infliximab; Isoxazoles; Leflunomide; Meloxicam; Methotrexate; Naproxen; Rheumatology; Thiazines; Thiazoles | 2006 |
[Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review].
Topics: Adalimumab; Aged; Animals; Animals, Domestic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Bone Marrow; Cats; Disease Reservoirs; Dog Diseases; Dogs; Drug Therapy, Combination; Duodenum; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Latent Tuberculosis; Leishmaniasis, Visceral; Methotrexate; Naproxen; Prednisone | 2010 |
Methotrexate for ankylosing spondylitis.
Topics: Antirheumatic Agents; Humans; Methotrexate; Naproxen; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing | 2013 |
Ascites and other incidental findings revealing undiagnosed systemic rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Ascites; Humans; Incidental Findings; Liver Function Tests; Male; Methotrexate; Naproxen; Pericardial Effusion; Pleural Effusion; Prednisolone; Referral and Consultation; Rheumatoid Factor; Rheumatoid Nodule; Treatment Outcome | 2015 |
3 trial(s) available for naproxen and methotrexate
Article | Year |
---|---|
Clinical investigation of methotrexate in the treatment of ankylosing spondylitis.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Naproxen; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome | 2001 |
Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Dizziness; Dose-Response Relationship, Drug; Female; Headache; Humans; Lansoprazole; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Naproxen; Nausea; Omeprazole; Vomiting | 2005 |
Observation of the clinical effect of the combined therapy of zushima tablet and western medicine in the treatment of rheumatoid arthritis and MRI test results.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Drugs, Chinese Herbal; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Naproxen; Prednisolone; Sulfasalazine; Tablets; Treatment Outcome; Western World | 2019 |
53 other study(ies) available for naproxen and methotrexate
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.
Topics: Chromatography, Affinity; Hydrogen-Ion Concentration; Ions; Models, Molecular; Molecular Conformation; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Serum Albumin, Bovine; Ultracentrifugation | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, antinociceptive and anti-inflammatory effects of porphyrins.
Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Edema; Erythrocytes; Hemolysis; Indomethacin; Male; Mice; Naproxen; Nociception; Pain; Pain Measurement; Porphyrins; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Psoriatic arthropathy].
Topics: Arthritis; Humans; Indomethacin; Methotrexate; Naproxen; Phenylbutazone; Psoriasis | 1977 |
Some effects of non-steroidal anti-inflammatory drugs on leucocyte migration.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Carrageenan; Cell Movement; Edema; Fenoprofen; Ibuprofen; Indomethacin; Ketoprofen; Leukocytes; Male; Methotrexate; Naproxen; Phenylbutazone; Pleurisy; Rats | 1976 |
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Proteins; Choline; Female; Humans; Ibuprofen; Kidney; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Naproxen; Protein Binding; Salicylates | 1992 |
A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cross-Sectional Studies; Diclofenac; Female; Gold; Humans; Ibuprofen; Male; Methotrexate; Middle Aged; Naproxen; Penicillamine; Piroxicam; Prednisolone; Prospective Studies; Spondylitis, Ankylosing; Sulfasalazine; United Kingdom | 1990 |
Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.
Topics: Absorption; Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Blood Proteins; Drug Therapy, Combination; Humans; Injections, Intravenous; Kidney; Metabolic Clearance Rate; Methotrexate; Middle Aged; Naproxen; Protein Binding | 1990 |
Fatal interaction between methotrexate and naproxen.
Topics: Arthritis, Rheumatoid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Methotrexate; Naproxen | 1986 |
Near fatal drug interactions with methotrexate given for psoriasis.
Topics: Aged; Aged, 80 and over; Drug Interactions; Female; Humans; Methotrexate; Naproxen; Necrosis; Pancytopenia; Psoriasis; Skin; Skin Ulcer; Trimethoprim | 1987 |
Interactions with the protein binding of 7-hydroxy-methotrexate in human serum in vitro.
Topics: Adult; Humans; Indomethacin; Male; Methotrexate; Naproxen; Protein Binding; Serum Albumin | 1988 |
Effects of naproxen and methotrexate on the extent of aortic lesions and cholesterol concentrations in cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Cell Division; Cholesterol; Diet, Atherogenic; Male; Methotrexate; Naproxen; Rabbits | 1980 |
Naproxen inhibits hepatic glycogenolysis induced by Ca(2+)-dependent agents.
Topics: Animals; Calcium; Glucagon; Liver; Liver Glycogen; Male; Methotrexate; Naproxen; Phenylephrine; Rats; Rats, Wistar | 1995 |
Histologic changes in rheumatoid synovitis induced by naproxen and methotrexate.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Arthritis, Rheumatoid; Female; HLA-DR Antigens; Humans; Male; Methotrexate; Middle Aged; Naproxen; Synovitis | 1993 |
Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis.
Topics: Adolescent; Adult; Arthritis, Juvenile; Biological Availability; Child; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Naproxen; Pilot Projects | 1993 |
Alterations in methotrexate pharmacokinetics by naproxen in the rat as measured by microdialysis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Folic Acid Antagonists; Hydroxylation; Kidney; Liver; Male; Methotrexate; Microdialysis; Naproxen; Rats; Rats, Wistar | 1997 |
Comparison of serum nitric oxide levels in active juvenile rheumatoid arthritis with those of patients in remission.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alkylating; Arthritis, Juvenile; Biomarkers; Blood Sedimentation; Child; Chlorambucil; Citrulline; Female; Health Status; Humans; Male; Methotrexate; Naproxen; Nitric Oxide; Predictive Value of Tests; Reactive Nitrogen Species; Reference Values; Remission Induction; Steroids; Surveys and Questionnaires; Up-Regulation | 2004 |
Immunosuppressants, infection, and inflammation.
Topics: Arthralgia; Arthritis, Juvenile; Child, Preschool; Fever; Humans; Immunosuppressive Agents; Infections; Inflammation; Male; Methotrexate; Naproxen | 2004 |
Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro.
Topics: Animals; Antirheumatic Agents; Benzodiazepines; Benzodiazepinones; Celecoxib; Cell Line; Cell Proliferation; Cell Survival; Diclofenac; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Inhibitory Concentration 50; Methotrexate; Naproxen; Pyrazoles; Quinoxalines; Sulfasalazine; Sulfonamides; Synovial Membrane | 2006 |
Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppressive Agents; Methotrexate; Naproxen; Prednisone; Time Factors; Tumor Virus Infections | 2006 |
Clinical and pathologic manifestations of necrobiosis lipoidica-like skin involvement in sarcoidosis.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Minocycline; Naproxen; Necrobiosis Lipoidica; Prednisone; Sarcoidosis; Treatment Outcome | 2007 |
Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA).
Topics: Administration, Oral; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Feasibility Studies; Female; Glucocorticoids; Humans; Hypnotics and Sedatives; Injections, Intra-Articular; Ketamine; Male; Methotrexate; Midazolam; Naproxen; Triamcinolone Acetonide | 2009 |
Development and validation of a composite disease activity score for juvenile idiopathic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Blood Sedimentation; Child; Child, Preschool; Cross-Sectional Studies; Disability Evaluation; Humans; Joints; Meloxicam; Methotrexate; Naproxen; Outcome Assessment, Health Care; Prognosis; Severity of Illness Index; Thiazines; Thiazoles; Treatment Outcome | 2009 |
Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs.
Topics: Aspartic Acid; Dendrimers; Drug Carriers; Histidine; Hydrogen-Ion Concentration; Methotrexate; Naproxen; Peptides; Pharmaceutical Preparations; Solubility; Surface Properties; Temperature; Water | 2010 |
[Clostridium difficile-associated diarrhea: causes and relationship to reactive arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Methotrexate; Middle Aged; Naproxen; Risk Factors | 2011 |
Inflammatory and noninflammatory arthropathy in patients with 18q deletion syndrome.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis; Child; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 18; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Naproxen; Prednisone; Synovitis | 2012 |
Skin manifestations associated with chronic recurrent multifocal osteomyelitis in a 9-year-old girl.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthralgia; Child; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Muscular Atrophy; Naproxen; Osteomyelitis; Paronychia; Psoriasis | 2014 |
[A man with a painful index finger].
Topics: Acrodermatitis; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Fingers; Humans; Male; Methotrexate; Middle Aged; Nails; Naproxen | 2016 |
Familial Juvenile Idiopathic Arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Male; Methotrexate; Naproxen; Siblings | 2017 |
Neutrophilic urticarial dermatosis as a presenting feature of systemic juvenile idiopathic arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child, Preschool; Colchicine; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Naproxen; Prednisolone; Skin; Sweet Syndrome; Tubulin Modulators | 2018 |
Structural efficacy of NSAIDs, COX-2 inhibitor and glucocorticoid compared with TNFα blocker: a study in adjuvant-induced arthritis rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Experimental; Celecoxib; Cyclooxygenase 2 Inhibitors; Etanercept; Glucocorticoids; Hindlimb; Methotrexate; Naproxen; Prednisone; Rats; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
An unusual cause of deforming erosive arthritis in an adult.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Arthritis; DNA Mutational Analysis; Humans; Male; Methotrexate; Mutation; Naproxen; Nod2 Signaling Adaptor Protein; Sarcoidosis; Synovitis; Uveitis; Wrist Joint | 2020 |
Chronic non-bacterial osteomyelitis of clavicle.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biopsy; Child; Chronic Disease; Clavicle; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Naproxen; Osteomyelitis; Radiography, Thoracic; Sarcoma, Ewing; Treatment Outcome | 2019 |
Evaluation of impaired growth plate development of long bones in skeletally immature mice by antirheumatic agents.
Topics: Animals; Antirheumatic Agents; Arthritis, Juvenile; Cell Differentiation; Cell Line; Chondrogenesis; Cyclooxygenase Inhibitors; Female; Growth Plate; Methotrexate; Mice, Inbred C57BL; Naproxen; Osteogenesis | 2021 |
Case report: crowned dens syndrome in a patient with seronegative rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Colchicine; Humans; Methotrexate; Naproxen; Neck Pain; Syndrome | 2023 |